115 related articles for article (PubMed ID: 23463806)
1. Efficacy of ambrisentan in the treatment of digital ulcers in patients with systemic sclerosis: a preliminary study.
Parisi S; Peroni CL; Laganà A; Scarati M; Ambrogio F; Bruzzone M; Fusaro E
Rheumatology (Oxford); 2013 Jun; 52(6):1142-4. PubMed ID: 23463806
[No Abstract] [Full Text] [Related]
2. Effect of the endothelin type A-selective endothelin receptor antagonist ambrisentan on digital ulcers in patients with systemic sclerosis: results of a prospective pilot study.
Chung L; Ball K; Yaqub A; Lingala B; Fiorentino D
J Am Acad Dermatol; 2014 Aug; 71(2):400-1. PubMed ID: 25037794
[No Abstract] [Full Text] [Related]
3. Effect of ambrisentan on digital ulcers in systemic sclerosis: a case report.
Tomaselli V; D'Ambrosio D; Massarelli L; Roccatello D
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-230-1. PubMed ID: 24774305
[No Abstract] [Full Text] [Related]
4. Brief report: effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: a prospective single-center, open-label pilot study.
Saggar R; Khanna D; Shapiro S; Furst DE; Maranian P; Clements P; Abtin F; Dua S; Belperio J; Saggar R
Arthritis Rheum; 2012 Dec; 64(12):4072-7. PubMed ID: 22777623
[TBL] [Abstract][Full Text] [Related]
5. Challenges in measuring outcomes: size assessment of an individual cutaneous lesion.
Okon L; Werth VP
J Am Acad Dermatol; 2014 Aug; 71(2):402-4. PubMed ID: 25037795
[No Abstract] [Full Text] [Related]
6. Effect of ambrisentan on peripheral circulation in patients with systemic sclerosis.
Sumida H; Asano Y; Hatano M; Aozasa N; Toyama T; Akamata K; Miyazaki M; Taniguchi T; Takahashi T; Ichimura Y; Noda S; Kuwano Y; Yanaba K; Sato S
Mod Rheumatol; 2016; 26(3):454-7. PubMed ID: 24593173
[TBL] [Abstract][Full Text] [Related]
7. Summaries for patients. Treatment of idiopathic pulmonary fibrosis with ambrisentan.
Ann Intern Med; 2013 May; 158(9):I-32. PubMed ID: 23785719
[No Abstract] [Full Text] [Related]
8. Ambrisentan (Letairis) for pulmonary arterial hypertension.
Med Lett Drugs Ther; 2007 Oct; 49(1272):87-8. PubMed ID: 17938611
[No Abstract] [Full Text] [Related]
9. Topical lidocaine helps reduce pain of digital ulcers in systemic sclerosis (scleroderma).
Ozgocmen S; Kaya A; Coskun BK
Clin Rheumatol; 2006 May; 25(3):378-9. PubMed ID: 16211339
[No Abstract] [Full Text] [Related]
10. ARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension.
Badesch DB; Feldman J; Keogh A; Mathier MA; Oudiz RJ; Shapiro S; Farber HW; McGoon M; Frost A; Allard M; Despain D; Dufton C; Rubin LJ;
Cardiovasc Ther; 2012 Apr; 30(2):93-9. PubMed ID: 21884013
[TBL] [Abstract][Full Text] [Related]
11. Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.
Raghu G; Behr J; Brown KK; Egan JJ; Kawut SM; Flaherty KR; Martinez FJ; Nathan SD; Wells AU; Collard HR; Costabel U; Richeldi L; de Andrade J; Khalil N; Morrison LD; Lederer DJ; Shao L; Li X; Pedersen PS; Montgomery AB; Chien JW; O'Riordan TG;
Ann Intern Med; 2013 May; 158(9):641-9. PubMed ID: 23648946
[TBL] [Abstract][Full Text] [Related]
12. Ambrisentan: new drug. Too risky in mildly symptomatic pulmonary hypertension.
Prescrire Int; 2009 Apr; 18(100):54. PubMed ID: 19585715
[TBL] [Abstract][Full Text] [Related]
13. Bosentan for digital ulcers in patients with systemic sclerosis: a prospective 3-year followup study.
Tsifetaki N; Botzoris V; Alamanos Y; Argyriou E; Zioga A; Drosos AA
J Rheumatol; 2009 Jul; 36(7):1550-2. PubMed ID: 19567637
[No Abstract] [Full Text] [Related]
14. Rituximab for refractory digital infarcts and ulcers in systemic sclerosis.
Khor CG; Chen XL; Lin TS; Lu CH; Hsieh SC
Clin Rheumatol; 2014 Jul; 33(7):1019-20. PubMed ID: 24722688
[TBL] [Abstract][Full Text] [Related]
15. Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials.
Khanna D; Denton CP; Merkel PA; Krieg T; Le Brun FO; Marr A; Papadakis K; Pope J; Matucci-Cerinic M; Furst DE; ;
JAMA; 2016 May; 315(18):1975-88. PubMed ID: 27163986
[TBL] [Abstract][Full Text] [Related]
16. New drugs: ambrisentan, temsirolimus, and eculizumab.
Hussar DA
J Am Pharm Assoc (2003); 2007; 47(5):664, 666-7, 669-71. PubMed ID: 17848357
[No Abstract] [Full Text] [Related]
17. Screening and Early Detection of Pulmonary Arterial Hypertension in Connective Tissue Diseases. It Is Time to Institute It!
Khanna D; McLaughlin V
Am J Respir Crit Care Med; 2015 Nov; 192(9):1032-3. PubMed ID: 26517415
[No Abstract] [Full Text] [Related]
18. Oral sildenafil in skin ulcers secondary to systemic sclerosis.
Della Rossa A; Doveri M; D'Ascanio A; Tavoni A; Consensi A; Neri R; Bazzichi L; Bombardieri S
Scand J Rheumatol; 2011; 40(4):323-5. PubMed ID: 21639825
[No Abstract] [Full Text] [Related]
19. A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis.
Chung L; Fiorentino D
J Am Acad Dermatol; 2006 May; 54(5):880-2. PubMed ID: 16635673
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of systemic sclerosis-related digital ulcers and sarcoidosis with endothelin receptor antagonist (bosentan) therapy.
Tillon J; Hervé F; Chevallier D; Muir JF; Levesque H; Marie I
Br J Dermatol; 2006 May; 154(5):1000-2. PubMed ID: 16634913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
